Clinical Trials
2 trialsNCT05363319 2026-05-13
CEMI-LUNG
Regeneron Pharmaceuticals
Recruiting
NCT06269133 2026-05-08
Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients
Regeneron Pharmaceuticals
Active not recruiting